e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
COPD: new markers of diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Targeting PI3KΔ or JAK in T-cells from COPD and severe asthma subjects reduces corticosteroid insensitive inflammatory responses
T. Southworth, J. Plumb, V. Gupta, I. Ramis, M. D. Lehner, D. Singh (Manchester, United Kingdom; Barcelona, Spain)
Source:
Annual Congress 2013 –COPD: new markers of diseases
Session:
COPD: new markers of diseases
Session type:
Thematic Poster Session
Number:
611
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Southworth, J. Plumb, V. Gupta, I. Ramis, M. D. Lehner, D. Singh (Manchester, United Kingdom; Barcelona, Spain). Targeting PI3KΔ or JAK in T-cells from COPD and severe asthma subjects reduces corticosteroid insensitive inflammatory responses. Eur Respir J 2013; 42: Suppl. 57, 611
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Expression of markers of activation and chemokine receptors by bronchoalveolar lavage T-cells from subjects with asthma, eosinophilic bronchitis and normal controls
Source: Eur Respir J 2001; 18: Suppl. 33, 530s
Year: 2001
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Pulmonary and systemic inflammation in patients with AECOPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Are there differences in the bronchoalveolar lavage (BAL) cytokine profile in children with and without allergic asthma?
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Characterization of an acute influenza infection in a murine model of allergic asthma and responses to corticosteroid
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Higher doses of inhaled steroid are associated with bacterial bronchitis in children with severe therapy resistant asthma (STRA)
Source: International Congress 2016 – Paediatric asthma: from amniotic fluid to dirty streets
Year: 2016
Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Involvement of the JAK-STAT3 pathway in a lipopolysaccharide-induced rat model of airway inflammation
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Sputum induction elicits different peripheral airways responses in healthy subjects, asthma and allergic rhinitis patients
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Altered apoptosis in bronchoalveolar lavage lymphocytes after allergen exposure of atopic asthmatic subjects
Source: Eur Respir J 2006; 28: 513-522
Year: 2006
Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006
Repeated lipopolysaccharide stimulation causes corticosteroid insensitive inflammation in lung via phosphoinositide-3-kinase δ signaling
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation
Source: Eur Respir J 2013; 41: 396-401
Year: 2013
Studies on apoptosis of alveolar lymphocytes (AL) in exogenous allergic alveolitis (EAA)
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Effects of cyclosporin H on airway inflammatory responses induced by mitochondrial damage-associated molecular patterns
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Airway dendritic cell phenotypes in inflammatory diseases of the human lung
Source: Eur Respir J 2007; 30: 878-886
Year: 2007
Lung microbiome is associated with asthma severity in fungal associated asthma
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept